Abstract
Bone tissue loss caused by various reasons including the accident trauma, tumor removal, or congenital deformity, etc., is a challenging problem in the clinic of orthopeadics, which brings the issue of bone grafting. The scaffold material is generally considered as the most important factor for tissue engineering. The development statuses of ceramics, polymers and their composites for bone tissue engineering have been reviewed in the present chapter. The composite strategy provides an effective way to fabricate scaffold biomaterial with tailorable physiochemical and/or mechanical properties. The composite scaffolds possessing both osteoconductivity and osteoinductivity appear to have a great potential for bone tissue engineering applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laurencin CT, et al. The ABJS Nicolas Andry award: tissue engineering of bone and ligament: a 15-year perspective. Clin Orthop Relat Res. 2006;447:221–36.
Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 2007;59(4–5):339–59.
Gazdag AR, et al. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg. 1995;3:1–8.
Wang M. Composites scaffolds for bone tissue engineering. Am J Biochem Biotech. 2006;2:80–4.
Laurencin CT, et al. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng. 1999;1:19–46.
Liu Q. Tissue engineering. In: Shi D, editor. Biomaterials and tissue engineering. Beijing: Tsinghua University Press; 2004. p. 195–246.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6.
Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21(24):2529–43.
Simpson RL, et al. Development of a 95/5 poly(L-lactide-co-glycolide)/hydroxylapatite and beta-tricalcium phosphate scaffold as bone replacement material via selective laser sintering. J Biomed Mater Res B Appl Biomater. 2008;84(1):17–25.
Jones JR, Ehrenfried LM, Hench LL. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials. 2006;27(7):964–73.
Shirtliff VJ, Hench LL. Bioactive materials for tissue engineering, regeneration and repair. J Mater Sci. 2003;38(23):4697–707.
Cerruti M, Sahai N. Silicate biomaterials for ortho- paedic and dental implants. Med Mineraology Geochemistry. 2006;64:283–313.
Rezwan K, et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27(18):3413–31.
Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials. 2003;24(13):2133–51.
Burg KJL, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials. 2000;21(23):2347–59.
Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev. 2005;16(3):329–45.
Reis RL, et al. Mechanical behavior of injection-molded starch-based polymers. Poly Adv Technol. 1996;7(10):784–90.
Cai K, et al. Physical and biological properties of a novel hydrogel composite based on oxidized alginate, gelatin and tricalcium phosphate for bone tissue engineering. Adv Eng Mater. 2007;9(12):1082–8.
Di Martino A, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials. 2005;26(30):5983–90.
Damoulis PD, et al. Osteogenic differentiation of human mesenchymal bone marrow cells in silk scaf- folds is regulated by nitric oxide. In: Zaidi M, editor. Skelet Biol Med Pt B. Oxford: Blackwell Publishing; 2007. p. 367–76.
Liu HF, et al. A comparison of rabbit mesenchymal stem cells and anterior cruciate ligament fibroblasts responses on combined silk scaffolds. Biomaterials. 2008;29(10):1443–53.
Cloyd JM, et al. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur Spine J. 2007;16(11):1892–8.
Lee SJ, Kim SY, Lee YM. Preparation of porous collagen/hyaluronic acid hybrid scaffolds for biomimetic functionalization through biochemical binding affinity. J Biomed Mater Res Part B Appl Biomater. 2007;82B(2):506–18.
Di Bella C, Farlie P, Penington AJ. Bone regeneration in a rabbit critical-sized skull defect using autologous adipose-derived cells. Tissue Eng Part A. 2008;14(4):483–90.
Mikos AG, et al. Wetting of poly(l-lactic acid) and poly(dl-lactic-co-glycolic acid) foams for tissue-culture. Biomaterials. 1994;15(1):55–8.
Pitt C, Gratzel M, Kimmel G. Aliphatic polyesters II. The degradation of poly(DL-lactide), poly(ε-caprolactone), and their copolymers in vivo. Biomaterials. 1981;2:215–20.
Toung JS, et al. Repair of a rodent nasal critical-size osseous defect with osteoblast augmented collagen gel. Laryngoscope. 1999;109(10):1580–4.
Peppas NA, Langer R. New challenges in biomaterials. Science. 1994;263(5154):1715–20.
Sims C, Butler P, Cao Y. Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast Reconstr Surg. 1998;101:1580–5.
Liu C, Xia Z, Czernuszka JT. Design and development of three-dimensional scaffolds for tissue engineering. Chem Eng Res Design. 2007;85(A7):1051–64.
Gabelnick H. Biodegradable implants: alternative approaches, in advanced in human fertility and reproductive endocrinology: vol. 2. In: Mishell D, editor. Long acting steroid contraception. New York: Raven Press; 1983. p. 149–73.
Chen GQ, Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials. 2005;26(33):6565–78.
Doi Y, Kitamura S, Abe H. Microbial synthesis and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Macromolecules. 1995;28(14):4822–8.
Doyle C, Tanner ET, Bonfield W. Invitro and invivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials. 1991;12(9):841–7.
Williams SF, et al. Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin: US, US 6623749 B2[P]. 2003.
Sakkers RJB, et al. Evaluation of copolymers of polyethylene oxide and polybutylene terephthalate (polyactive): mechanical behaviour. J Mater Sci Mater Med. 1998;9(7):375–9.
Radder AM, et al. The PEO/PBT copolymer-mineralized matrix interface in-vitro. Cells Mater. 1993;3(4):367–76.
Radder AM, Leenders H, Vanblitterswijk CA. Interface reactions to PEO/PBT copolymers (Polyactive(R)) after implantation in cortical bone. J Biomed Mater Res. 1994;28(2):141–51.
Radder AM, et al. Interfacial behavior of PEO/PBT copolymers (Polyactive(R)) in a calvarial system – an in-vitro study. J Biomed Mater Res. 1994;28(2):269–77.
Weigel T, Schinkel G, Lendlein A. Design and preparation of polymeric scaffolds for tissue engineering. Expert Rev Med Devices. 2006;3(6):835–51.
Mikos AG, et al. Preparation and characterization of poly(l-lactic acid) foams. Polymer. 1994;35(5):1068–77.
Mikos AG, et al. Laminated 3-dimensional biodegradable foams for use in tissue engineering. Biomaterials. 1993;14(5):323–30.
Whang K, Goldstick TK, Healy KE. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials. 2000;21(24):2545–51.
Whang K, et al. A novel method to fabricate bioabsorbable scaffolds. Polymer. 1995;36(4):837–42.
Wu L, Ding J. Advances in fabrication methodology and technology of three-dimensional porous scaffolds for tissue engineering. J Funct Polym. 2003;16(1):91–6.
Pini R, et al. Sorption and swelling of poly(DL-lactic acid) and poly(lactic-co-glycolic acid) in supercritical CO2: an experimental and modeling study. J Polym Sci B Polym Phys. 2008;46(5):483–96.
Tai H, et al. Putting the fizz into chemistry: applications of supercritical carbon dioxide in tissue engineering, drug delivery and synthesis of novel block copolymers. Biochem Soc Trans. 2007;35:516–21.
Barry JJA, et al. Supercritical carbon dioxide: putting the fizz into biomaterials. Philos Transact R Soc A Math Phys Eng Sci. 2006;364(1838):249–61.
Collins NJ, et al. The influence of silica on pore diameter and distribution in PLA scaffolds produced using supercritical CO2. J Mater Sci Mater Med. 2008;19(4):1497–502.
Liu L, et al. Porous morphology, porosity, mechanical properties of poly(alpha-hydroxy acid)-tricalcium phosphate composite scaffolds fabricated by low-temperature deposition. J Biomed Mater Res A. 2007;82A(3):618–29.
Park A, Wu B, Griffith LG. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion. J Biomater Sci Polym Ed. 1998;9(2):89–110.
Cima LG, et al. Tissue engineering by cell transplantation using degradation using degradable polymer substrates. J Biomech Eng Transact Asme. 1991;113(2):143–51.
Beaman J. Bachround and definitions. In: Beaman J, et al., editors. Solid free-form fabrications: a new direction in manufacturing. Boston: Kluwer Academic Publishers; 1997. p. 1–20.
Yang S, et al. The design of scaffolds for use in tissue engineering. Part 2. Rapid prototyping techniques. Tissue Eng. 2002;8(1):1–11.
Agarwala M, et al. Structural quality of parts processed by fused deposition. Rapid Prototyping J. 1996;2(4):4–19.
Chua CK, et al. Development of a tissue engineering scaffold structure library for rapid prototyping. Part 1: Investigation and classification. Int J Adv Manuf Technol. 2003;21(4):291–301.
Li HY, Lin KL, Chang J. Preparation of macroporous polymer scaffolds using calcined cancellous bone as a template. J Biomater Sci Polym Ed. 2005;16(5):575–84.
Yoon BH, et al. Aligned porous alumina ceramics with high compressive strengths for bone tissue engineering. Scr Mater. 2008;58(7):537–40.
Chevalier J. What future for zirconia as a biomaterial? Biomaterials. 2006;27(4):535–43.
Murashima Y, et al. Calcium sulphate as a bone substitute for various osseous defects in conjunction with apicectomy. Int Endod J. 2002;35(9):768–74.
Cui L, et al. Repair of cranial bone defects with adipose derived stem cells and coral scaffold in a canine model. Biomaterials. 2007;28(36):5477–86.
Pillar R, et al. Porous calcium pyrophosphate scaffolds for bone substitute applications – in vitro characterization. Biomaterials. 2001;22:963–72.
Yoon BH, et al. In-situ fabrication of porous hydroxyapatite (HA) scaffolds with dense shells by freezing HA/camphene slurry. Mater Lett. 2008;62(10–11):1700–3.
Kumta PN, et al. Nanostructured calcium phosphates for biomedical applications: novel synthesis and characterization. Acta Biomater. 2005;1(1):65–83.
Suzuki O, et al. Bone regeneration by synthetic octacalcium phosphate and its role in biological mineralization. Curr Med Chem. 2008;15(3):305–13.
Jarcho M, et al. Hydroxylapatite synthesis and characterization in dense polycrystalline form. J Mater Sci. 1976;11:2027–35.
de Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials. 1980;1(1):47–50.
Akao H, Aoki H, Kato K. Mechanical properties of sintered hydroxyapatite for prosthetic application. J Mater Sci. 1981;16:809–12.
Klein C, Patka P, den Hollander W. Macroporous calcium phosphate bioceramics in dog femora: a histological study of interface and biodegration. Biomaterials. 1989;10:59–62.
Walsh WR, et al. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials. 2008;29(3):266–71.
Ohgushi H, et al. Bone-formation process in porous calcium-carbonate and hydroxyapatite. J Biomed Mater Res. 1992;26(7):885–95.
Ripamonti U, et al. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg. 1992;90(3):382–93.
Bucholz R, Charlton A, Holmes R. Hydroxyaptite and tricalcium phosphate bone-graft substitutes. Orthop Clin North Am. 1987;18:323–34.
Jensen TB, et al. Bone allograft, Pro-osteon 200 (R) and osteogenic protein-1 device (R) around noncemented implants. Bone. 1999;24(4):428–428.
Okumura N, et al. Organ regeneration in porous hydroxyapatite. Bioceramics. 2006;18(Pts 1 and 2):1017–20.
Wang M. Bioactive materials and processing. In: Shi D, editor. Biomaterials and tissue engineering. Beijing: Tsinghua University Press; 2004. p. 1–82.
Bareille R, et al. Various evaluation techniques of newly formed bone in porous hydroxyapatite loaded with human bone marrow cells implanted in an extra-osseous site. Biomaterials. 2000;21(13):1345–52.
Fabbri M, Celotti GC, Ravaglioli A. Hydroxyapatite-based porous aggregates – physicochemical nature, structure, texture and architecture. Biomaterials. 1995;16(3):225–8.
Almirall A, et al. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an alpha-TCP paste. Biomaterials. 2004;25(17):3671–80.
Deville S, Saiz E, Tomsia AP. Freeze casting of hydroxyapatite scaffolds for bone tissue engineering. Biomaterials. 2006;27(32):5480–9.
Tian JT, Tian JM. Preparation of porous hydroxyapatite. J Mater Sci. 2001;36(12):3061–6.
Tancred DC, McCormack BAO, Carr AJ. A synthetic bone implant macroscopically identical to cancellous bone. Biomaterials. 1998;19(24):2303–11.
Yoshikawa T. Bone reconstruction by cultured bone graft. Mater Sci Eng C. 2000;13:29–37.
Mendes SC, et al. Cultured living bone equivalents enhance bone formation when compared to a cell seeding approach. Bioceramics. 2002;14:227–31.
Pietak AM, et al. Silicon substitution in the calcium phosphate bioceramics. Biomaterials. 2007;28(28):4023–32.
Mastrogiacomo M, et al. Tissue engineering of bone: search for a better scaffold. Orthod Craniofac Res. 2005;8(4):277–84.
Elliot J. Structure and chemistry of the apatites and other calcium orthophosphates. New York: Elsevier Science; 1994.
Lee Y, et al. Preparation and characterization of macroporous carbonate-substituted hydroxyapatite scaffold. Ind Eng Chem Res. 2008;47(8):2618–22.
Yasukawa A, et al. Ion-exchange of magnesium-calcium hydroxyapatite solid solution particles with Cd2+ ion. Colloids Surf A Physicochem Eng Aspects. 2008;317(1–3):123–8.
Barinov SM, et al. Stabilization of carbonate hydroxyapatite by isomorphic substitutions of sodium for calcium. Russ J Inorg Chem. 2008;53(2):164–8.
Kannan S, et al. Ionic substitutions in biphasic hydroxyapatite and beta-tricalcium phosphate mixtures: structural analysis by rietveld refinement. J Am Ceram Soc. 2008;91(1):1–12.
Kannan S, et al. Fluorine-substituted hydroxyapatite scaffolds hydrothermally grown from aragonitic cuttlefish bones. Acta Biomater. 2007;3(2):243–9.
Li MO, et al. Structural characterization of zinc-substituted hydroxyapatite prepared by hydrothermal method. J Mater Sci Mater Med. 2008;19(2):797–803.
Lin YG, Yang ZR, Jiang C. Preparation, characterization and antibacterial property of cerium substituted hydroxyapatite nanoparticles. J Rare Earths. 2007;25(4):452–6.
Wang XP, Ye JD. Variation of crystal structure of hydroxyapatite in calcium phosphate cement by the substitution of strontium ions. J Mater Sci Mater Med. 2008;19(3):1183–6.
Kim SR, et al. Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials. 2003;24(8):1389–98.
Langstaff S, et al. Resorbable bioceramics based on stabilized calcium phosphates. Part II: evaluation of biological response. Biomaterials. 2001;22(2):135–50.
Chen Y, et al. In vitro behavior of osteoblast-like cells on PLLA films with a biomimetic apatite or apatite/collagen composite coating. J Mater Sci Mater Med. 2008;19(6):2261–8.
Forsgren J, et al. Formation and adhesion of biomimetic hydroxyapatite deposited on titanium substrates. Acta Biomater. 2007;3(6):980–4.
Kamitakahara M, Ohtsuki C, Miyazaki T. Coating of bone-like apatite for development of bioactive materials for bone reconstruction. Biomed Mater. 2007;2(4):R17–23.
Klopcic SB, Kovac J, Kosmac T. Apatite-forming ability of alumina and zirconia ceramics in a supersaturated Ca/P solution. Biomol Eng. 2007;24(5):467–71.
Tuzlakoglu K, Reis RL. Formation of bone-like apatite layer on chitosan fiber mesh scaffolds by a biomimetic spraying process. J Mater Sci Mater Med. 2007;18(7):1279–86.
Yang F, Wolke JGC, Jansen JA. Biomimetic calcium phosphate coating on electrospun poly (epsilon-caprolactone) scaffolds for bone tissue engineering. Chem Eng J. 2008;137(1):154–61.
Leonor IB, et al. Biomimetic apatite formation on different polymeric microspheres modified with calcium silicate solutions. Bioceramics. 2006;18(Pts 1 and 2):279–82.
Zhang EL, Yang K. Biomimetic coating of calcium phosphate on biometallic materials. Transact Nonferrous Met Soc Chin. 2005;15(6):1199–205.
Carlise E. Si: a possible factor in bone calcification. Science. 1970;167:279–80.
Jugdaohsingh R, et al. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Miner Res. 2004;19(2):297–307.
Vallet-Regi M, Arcos D. Silicon substituted hydroxyapatites. A method to upgrade calcium phosphate based implants. J Mater Chem. 2005;15(15):1509–16.
Ruys A. Silicon doped hydroxyapatite. J Aust Ceram Soc. 1993;29:71–80.
Gibson I, et al. Effect of Si content on the chemical and phase composition of novel Si substituted hydroxyaptites. In: LeGeros RaL J, editor. Bioceramics. Singapore: World Scientific Publishing; 1998. p. 105–8.
Gibson I, Best S, Bonfield W. Effect of silicon substitution on the sintering and microstructure of hydroxyaptite. J Am Ceram Soc. 2002;85:2771–7.
Li XW, Yasuda HY, Umakoshi Y. Bioactive ceramic composites sintered from hydroxyapatite and silica at 1200 degrees C: preparation, microstructures and in vitro bone-like layer growth. J Mater Sci Mater Med. 2006;17(6):573–81.
Porter AE, et al. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. J Biomed Mater Res A. 2004;69A(4):670–9.
Xynos ID, et al. Bioglass (R) 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int. 2000;67(4):321–9.
Black J, Hastings G. Handbook of biomaterials properties. London: Chapman & Hall; 1998.
Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials. 1999;20(23–24):2287–303.
Eggli P, Müller W, Schenk R. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. Clin Orthop. 1988;232:127–38.
Kamitakahara M, et al. Control of the microstructure of porous tricalcium phosphate: effects of addition of Mg, Zn and Fe. J Japan Soc Powder Powder Metallurgy. 2005;52:256–359.
Ryu HS, et al. An improvement in sintering property of beta-tricalcium phosphate by addition of calcium pyrophosphate. Biomaterials. 2002;23(3):909–14.
Mastrogiacomo M, et al. Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. Biomaterials. 2007;28(7):1376–84.
Descamps M, et al. Synthesis of macroporous [beta]-tricalcium phosphate with controlled porous architectural. Ceram Int. 2008;34(5):1131–7.
Descamps M, et al. Manufacture of macroporous [beta]-tricalcium phosphate bioceramics. J Eur Ceram Soc. 2008;28(1):149–57.
Xie YZ, et al. Three-dimensional flow perfusion culture system for stem cell proliferation inside the critical-size beta-tricalcium phosphate scaffold. Tissue Eng. 2006;12(12):3535–43.
Guo XM, et al. Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into beta-tricalcium phosphate in a sheep model. Tissue Eng. 2004;10(11–12):1818–29.
Guo XM, et al. Repair of osteochondral defects with autologous chondrocytes seeded onto bioceramic scaffold in sheep. Tissue Eng. 2004;10(11–12):1830–40.
Zhang F, et al. Bioinspired structure of bioceramics for bone regeneration in load-bearing sites. Acta Biomater. 2007;3(6):896–904.
Nery EB, et al. Tissue-response to biphasic calcium-phosphate ceramic with different ratios of ha/beta-tcp in periodontal osseous defects. J Periodontol. 1992;63(9):729–35.
Wang JX, et al. Biological evaluation of biphasic calcium phosphate ceramic vertebral laminae. Biomaterials. 1998;19(15):1387–92.
Ramay HRR, Zhang M. Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials. 2004;25(21):5171–80.
Kwon SH, et al. Synthesis and dissolution behavior of beta-TCP and HA/beta-TCP composite powders. J Eur Ceram Soc. 2003;23(7):1039–45.
Kohri M, et al. Invitro stability of biphasic calcium-phosphate ceramics. Biomaterials. 1993;14(4):299–304.
Yuan HP, et al. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng. 2006;12(6):1607–15.
Yuan HP, et al. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med. 2002;13(12):1271–5.
Ng AMH, et al. Differential osteogenic activity of osteoprogenitor cells on HA and TCP/HA scaffold of tissue engineered bone. J Biomed Mater Res A. 2008;85A(2):301–12.
Hench LL, et al. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp. 1971;2:117–41.
Cao WP, Hench LL. Bioactive materials. Ceram Int. 1996;22(6):493–507.
Hench LL. Bioceramics. J Am Ceram Soc. 1998;81(7):1705–28.
Hench LL, Wilson J. Surface-active biomaterials. Science. 1984;226:630–6.
Xynos ID, et al. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun. 2000;276(2):461–5.
Hench LL. Bioceramics – from concept to clinic. J Am Ceram Soc. 1991;74(7):1487–510.
Xynos ID, et al. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass? 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151–7.
Hench LL. The challenge of orthopaedic materials. Curr Orthop. 2000;14(1):7–15.
Balamurugan A, et al. Sol gel derived SiO2-CaO-MgO-P2O5 bioglass system-preparation and in vitro characterization. J Biomed Mater Res B Appl Biomater. 2007;83B(2):546–53.
Karpov M, et al. Sol–gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells. J Biomed Mater Res A. 2008;84A(3):718–26.
Yi J, et al. Sol–gel derived mesoporous bioactive glass fibers as tissue-engineering scaffolds. J Solgel Sci Technol. 2008;45(1):115–9.
Du RL, Chang J. The influence of Zn on the deposition of HA on sol–gel derived bioactive glass. Biomed Mater Eng. 2006;16(4):229–36.
Hamadouche M, et al. Absorbability of bulk sol–gel 1756 bioactive glasses. Bioceramics. 2000;192(1):593–96.
Zhong JP, Greenspan DC. Processing and properties of sol–gel bioactive glasses. J Biomed Mater Res. 2000;53(6):694–701.
Livage J. Sol–gel processes. Curr Opin Solid State Mater Sci. 1997;2(2):132–8.
Pereira MM, Clark AE, Hench LL. Calcium-phosphate formation on sol–gel-derived bioactive glasses in-vitro. J Biomed Mater Res. 1994;28(6):693–8.
Pereira MM, Clark AE, Hench LL. Homogeneity and bioactivity of sol–gel derived glasses. J Dent Res. 1994;73:276–276.
Ohura K, et al. Bioactivity of CaO•SiO2 glasses added with various ions. J Mater Sci Mater Med. 1992;3:95–100.
Yuan HP, et al. Bone induction by porous glass ceramic made from Bioglass (R) (45S5). J Biomed Mater Res. 2001;58(3):270–6.
Chen QZZ, Thompson ID, Boccaccini AR. 45S5 Bioglass (R)-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials. 2006;27(11):2414–25.
Kaufmann E, Ducheyne P, Shapiro IM. Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation. J Biomed Mater Res. 2000;52(4):783–96.
Livingston T, Ducheyne P, Garino J. In vivo evaluation of a bioactive scaffold for bone tissue engineering. J Biomed Mater Res. 2002;62(1):1–13.
Peitl O, LaTorre GP, Hench LL. Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res. 1996;30(4):509–14.
Li P, et al. The effect of residual glassy phase in a bioactive glass-ceramic on the formation of its surface apatite layer invitro. J Mater Sci Mater Med. 1992;3(6):452–6.
Jones JR, Hench LL. Effect of surfactant concentration and composition on the structure and properties of sol–gel-derived bioactive glass foam scaffolds for tissue engineering. J Mater Sci. 2003;38(18):3783–90.
Jones JR, Hench LL. Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering. J Biomed Mater Res B Appl Biomater. 2004;68B(1):36–44.
Jones JR, Lee PD, Hench LL. Hierarchical porous materials for tissue engineering. Philos Transact R Soc A Math Phys Eng Sci. 2006;364(1838):263–81.
Sepulveda P, Jones JR, Hench LL. Bioactive sol–gel foams for tissue repair. J Biomed Mater Res. 2002;59(2):340–8.
White RA, Weber JN, White EW. Replamineform: a new process for preparing porous ceramic, metal, and polymer prosthetic materials. Science. 1972;176(4037):922–4.
Habraken WJEM, Wolke JGC, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59(4–5):234–48.
Sepulveda P, Jones JR, Hench LL. In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses. J Biomed Mater Res. 2002;61(2):301–11.
Kokubo T, et al. Apatite- and wollastonite-containing glass-ceramics for prosthetic application. Bull Inst Chem Res Kyoto Univ. 1982;60:260–68.
Kokubo T, et al. Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res. 1990;24(3):331–43.
Dyson JA, et al. Development of custom-built bone scaffolds using mesenchymal stem cells and apatite-wollastonite glass-ceramics. Tissue Eng. 2007;13(12):2891–901.
Jones JR, Hench LL. Materials perspective – biomedical materials for new millennium: perspective on the future. Mater Sci Technol. 2001;17(8):891–900.
Ohtsuki C, et al. Apatite formation on the surface of ceravital-type glass-ceramic in the body. J Biomed Mater Res. 1991;25(11):1363–70.
Reck R, Storkel S, Meyer A. Ceravital middle-ear prostheses – long-term follow-ups. Laryngologie Rhinologie Otologie Vereinigt Mit Monatsschrift Fur Ohrenheilkunde. 1987;66(7):373–6.
Dost P, et al. Reconstruction of the stapes superstructure with a combined glass-ceramic (Bioverit((R))) implant in guinea pigs. ORL J Otorhinolaryngol Relat Spec. 2002;64(6):429–32.
Jutte M, et al. Bioverit(R) enucleation protheses in rabbits. Klin Monatsbl Augenheilkd. 1992;200(6):674–7.
Vitale-Brovarone C, et al. Macroporous glass-ceramic materials with bioactive properties. J Mater Sci Mater Med. 2004;15(3):209–17.
Vitale-Brovarone C, et al. Development of glass-ceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater. 2007;3(2):199–208.
Vitale-Brovarone C, et al. Biocompatible glass-ceramic materials for bone substitution. J Mater Sci Mater Med. 2008;19(1):471–8.
Ramp WK, Lenz LG, Kaysinger KK. Medium pH modulates matrix, mineral, and energy-metabolism in cultured chick bones and osteoblast-like cells. Bone Miner. 1994;24(1):59–73.
Kaysinger KK, Ramp WK. Extracellular pH modulates the activity of cultured human osteoblasts. J Cell Biochem. 1998;68(1):83–9.
Conzone SD, et al. In vitro and in vivo dissolution behavior of a dysprosium lithium borate glass designed for the radiation synovectomy treatment of rheumatoid arthritis. J Biomed Mater Res. 2002;60(2):260–8.
Day DE, et al. Transformation of borate glasses into biologically useful materials. Glass Technol. 2003;44(2):75–81.
Liang W, et al. Bioactive borate glass scaffold for bone tissue engineering. J Non Cryst Solids. 2008;354(15–16):1690–6.
Kasuga T. Bioactive calcium pyrophosphate glasses and glass-ceramics. Acta Biomater. 2005;1(1):55–64.
Wang C, Kasuga T, Nogami M. Macroporous calcium phosphate glass-ceramic prepared by two-step pressing technique and using sucrose as a pore former. J Mater Sci Mater Med. 2005;16(8):739–44.
Kasuga T, Abe Y. Novel calcium phosphate ceramics prepared by powder sintering and crystallization of glasses in the pyrophosphate region. J Mater Res. 1998;13(12):3357–60.
Kasuga T, Abe Y. Calcium phosphate invert glasses with soda and titania. J Non Cryst Solids. 1999;243(1):70–4.
Kasuga T, et al. Bioactive ceramics prepared by sintering and crystallization of calcium phosphate invert glasses. Biomaterials. 1999;20(15):1415–20.
Navarro M, et al. Development of a new calcium phosphate glass ceramic porous scaffold for guided bone regeneration. Bioceramics. 2004;16:945–8.
Deaza PN, Guitian F, Deaza S. Bioactivity of wollastonite ceramics – in-vitro evaluation. Scripta Metallurgica Et Materialia. 1994;31(8):1001–5.
Liu XY, Ding CX, Chu PK. Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Biomaterials. 2004;25(10):1755–61.
Lin KL, et al. A simple method to synthesize single-crystalline beta-wollastonite nanowires. J Crystal Growth. 2007;300(2):267–71.
Liu XY, Ding CX. Reactivity of plasma-sprayed wollastonite coating in simulated body fluid. J Biomed Mater Res. 2002;59(2):259–64.
Xue WC, et al. In vivo evaluation of plasma-sprayed wollastonite coating. Biomaterials. 2005;26(17):3455–60.
Zhang FM, et al. Preparation, mechanical properties and in vitro degradability of wollastonite/tricalcium phosphate macroporous scaffolds from nanocomposite powders. J Mater Sci Mater Med. 2008;19(1):167–73.
De Aza PN, et al. Morphological studies of pseudowollastonite for biomedical application. J Microsc Oxford. 1996;182:24–31.
De Aza PN, et al. Bioactivity of pseudowollastonite in human saliva. J Dent. 1999;27(2):107–13.
De Aza PN, et al. Transmission electron microscopy of the interface between bone and pseudowollastonite implant. J Microsc Oxford. 2001;201:33–43.
Siriphannon P, et al. Influence of preparation conditions on the microstructure and bioactivity of alpha-CaSiO3 ceramics: formation of hydroxyapatite in simulated body fluid. J Biomed Mater Res. 2000;52(1):30–9.
Sarmento C, et al. In vitro behavior of osteoblastic cells cultured in the presence of pseudowollastonite ceramic. J Biomed Mater Res A. 2004;69A(2):351–8.
de Aza PN, et al. Morphological and structural study of pseudowollastonite implants in bone. J Microsc Oxford. 2000;197:60–7.
Gou ZR, et al. In vitro bioactivity and dissolution of Ca-2(SiO3)(OH)(2) and beta-Ca2SiO4 fibers. J Eur Ceram Soc. 2004;24(13):3491–7.
Gou ZR, Chang J, Zhai WY. Preparation and characterization of novel bioactive dicalcium silicate ceramics. J Eur Ceram Soc. 2005;25(9):1507–14.
Zhao WY, et al. In vitro bioactivity of novel tricalcium silicate ceramics. J Mater Sci Mater Med. 2007;18(5):917–23.
Zhao WY, Chang J. Sol–gel synthesis and in vitro bioactivity of tricalcium silicate powders. Mater Lett. 2004;58(19):2350–3.
Wu CT, Chang J. A novel akermanite bioceramic: preparation and characteristics. J Biomater Appl. 2006;21(2):119–29.
Wu CT, Chang J. Synthesis and apatite-formation ability of akermanite. Mater Lett. 2004;58(19):2415–7.
Wu CT, et al. In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A. 2006;76A(1):73–80.
Wu CT, Chang J. Synthesis and in vitro bioactivity of bredigite powders. J Biomater Appl. 2007;21(3):251–63.
Wu CT, et al. A novel bioactive porous bredigite (Ca7MgSi4O16) scaffold with biomimetic apatite layer for bone tissue engineering. J Mater Sci Mater Med. 2007;18(5):857–64.
Nonami T, Tsutsumi S. Study of diopside ceramics for biomaterials. J Mater Sci Mater Med. 1999;10(8):475–9.
De Aza PN, Luklinska ZB, Anseau M. Bioactivity of diopside ceramic in human parotid saliva. J Biomed Mater Res B Appl Biomater. 2005;73B(1):54–60.
Iwata NY, et al. Sintering behavior and apatite formation of diopside prepared by coprecipitation process. Colloids Surf B Biointerfaces. 2004;34(4):239–45.
Du RL, Chang J. Preparation and characterization of bioactive sol–gel-derived Na2Ca2Si3O9. J Mater Sci Mater Med. 2004;15(12):1285–9.
Lu WH, Duan W, Guo YP, Ning CQ. Mechanical properties and in vitro bioactivity of Ca5(PO4)2SiO4 bioceramic. J Biomater Appl. 2012;26:637–50.
Duan W, Ning CQ, Tang TT. Cytocompatibility and osteogenic activity of a novel calcium phosphate silicate bioceramic: silicocarnotite. J Biomed Mater Res A. 2013;101A(7):1955–61.
El-Ghannam A, Cunningham L, Pienkowski D, Hart A. Bone engineering of the rabbit ulna. J Oral Maxillofac Surg. 2007;65:1495–502.
El-Ghannam A, Ning C, Mehta J. Cyclosilicate nanocomposite: A novel resorbable bioactive tissue engineering scaffold for BMP and bone marrow cell delivery. J Biomed Mater Res. 2004;71A:377–90.
Ni SY, Chang J, Chou L. A novel bioactive porous CaSiO3 scaffold for bone tissue engineering. J Biomed Mater Res A. 2006;76A(1):196–205.
Ni SY, et al. Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. J Biomed Mater Res B Appl Biomater. 2007;80B(1):174–83.
Xu S, et al. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials. 2008;29(17):2588–96.
Dufrane D, et al. Indirect cytotoxicity evaluation of pseudowollastonite. J Mater Sci Mater Med. 2003;14(1):33–8.
Lin KL, et al. Study of the mechanical property and in vitro biocompatibility of CaSiO3 ceramics. Ceram Int. 2005;31(2):323–6.
Siriphannon P, et al. Preparation and sintering of CaSiO3 from coprecipitated powder using NaOH as precipitant and its apatite formation in simulated body fluid solution. J Mater Res. 1999;14(2):529–36.
Sahai N, Anseau M. Cyclic silicate active site and stereochemical match for apatite nucleation on pseudowollastonite bioceramic-bone interfaces. Biomaterials. 2005;26:5763–70.
Gou ZG, Chang J. Synthesis and in vitro bioactivity of dicalcium silicate powders. J Eur Ceram Soc. 2004;24(1):93–9.
Nakajima S, et al. Physicochemical characteristics of new reinforcement ceramic implant. Shikwa Gakuho. 1989;89:1709–17.
Nakajima S. Experimental studies of healing process on reinforcement ceramic implantation in rabbit mandible. Shikwa Gakuho. 1990;4:525–53.
Miake Y, et al. High resolution and analytical electron microscopic studies of new crystals induced by a bioactive ceramic (diopside). J Dent Res. 1995;74(11):1756–63.
Iwata NY, et al. Preparation of diopside with apatite-forming ability by sol–gel process using metal alkoxide and metal salts. Colloids Surf B Biointerfaces. 2004;33(1):1–6.
Wu CT, et al. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials. 2005;26(16):2925–31.
Arcos D, Greenspan DC, Vallet-Regi M. A new quantitative method to evaluate the in vitro bioactivity of melt and sol–gel-derived silicate glasses. J Biomed Mater Res A. 2003;65A(3):344–51.
Sun HL, et al. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials. 2006;27(33):5651–7.
De Aza PN, Guitian F, DeAza S. Bioeutectic: a new ceramic material for human bone replacement. Biomaterials. 1997;18(19):1285–91.
De Aza PN, et al. Reactivity of a wollastonite-tricalcium phosphate bioeutectic (R) ceramic in human parotid saliva. Biomaterials. 2000;21(17):1735–41.
Huang XA, Jiang DL, Tan SH. Apatite formation on the surface of wollastonite/tricalcium phosphate composite immersed in simulated body fluid. J Biomed Mater Res B Appl Biomater. 2004;69B(1):70–2.
Ni SY, et al. Beta-CaSiO3/beta-Ca-3(PO4)(2) composite materials for hard tissue repair: in vitro studies. J Biomed Mater Res A. 2008;85A(1):72–82.
Li HY, Chang J. Preparation and characterization of bioactive and biodegradable Wollastonite/poly(D, L-lactic acid) composite scaffolds. J Mater Sci Mater Med. 2004;15(10):1089–95.
Li HY, Chang J. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds. Biomaterials. 2004;25(24):5473–80.
Cheng W, Li HY, Chang J. Fabrication and characterization of beta-dicalcium silicate/poly(D, L-lactic acid) composite scaffolds. Mater Lett. 2005;59(17):2214–8.
Sada E, Kumazawa H, Murakami Y. Hydrothermal synthesis of crystalline hydroxyapatite ultrafine particles. Chem Eng Commun. 1991;103:57–64.
Fang Y, et al. Ultrasonically accelerated synthesis of hydroxyapatite. J Mater Res. 1992;7(8):2294–8.
Zhang SM, et al. Interfacial fabrication and property of hydroxyapatite/polylactide resorbable bone fixation composites. Curr Appl Phys. 2005;5(5):516–8.
Qiu XY, et al. Hydroxyapatite surface modified by L-lactic acid and its subsequent grafting polymerization of L-lactide. Biomacromolecules. 2005;6(3):1193–9.
Qiu XY, et al. Surface-modified hydroxyapatite linked by L-lactic acid oligomer in the absence of catalyst. J Polym Sci A Polym Chem. 2005;43(21):5177–85.
Ye LZ, et al. Fabrication of poly-(DL-lactic acid)-wollastonite composite films with surface modified beta-CaSiO3 particles. J Biomater Appl. 2008;22(5):465–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag London
About this chapter
Cite this chapter
Ning, C. (2016). Biomaterials for Bone Tissue Engineering. In: Poitout, D. (eds) Biomechanics and Biomaterials in Orthopedics. Springer, London. https://doi.org/10.1007/978-1-84882-664-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-84882-664-9_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-663-2
Online ISBN: 978-1-84882-664-9
eBook Packages: MedicineMedicine (R0)